Overwhelmed or confused by AI and machine learning technology? A new analysis in European Heart Journal hopes to provide some clarity. 

Fuster, one of the world’s most prominent cardiologists, said the award was a "great honor," especially since he was born in Barcelona. 

“There has never been a more exciting time to be a cardiothoracic surgeon,” the veteran surgeon said in a statement. 

Researchers examined data from nearly 2 million patients, sharing their full findings in JACC: Cardiovascular Imaging.

The newly approved SGLT2 inhibitor, bexagliflozin, is marketed under the name Brenzavvy. It is not recommended for patients with type 1 diabetes. 

The topic was explored at length in a new scientific statement presented at the 59th Annual Meeting of the Society of Thoracic Surgeons.

Northwestern's Clyde Yancy, MD, discusses how his health system is addressing health access equity issues with plans to open a new outpatient clinic on the historically Black Chicago South Side.

The IVL technology developed by Shockwave Medical helped clinicians treat a TMVR patient who had previously undergone TAVR. Could this be a common use of IVL in the future?

The medications included in the program treat more than 80 conditions.

Under the new proposal, the FDA would conduct an assessment of prevalent strains circulating each year, likely beginning around June, with the aim of new vaccines being ready by September.